Literature DB >> 16731462

Multicenter experience with failed and recalled implantable cardioverter-defibrillator pulse generators.

Robert G Hauser1, David L Hayes, Andrew E Epstein, David S Cannom, Stephen C Vlay, Susan L Song, G Frank O Tyers.   

Abstract

BACKGROUND: Despite the widespread and growing use of implantable cardioverter-defibrillators (ICDs), little information is available regarding their performance or the impact of advanced pacing functions on ICD reliability and longevity.
OBJECTIVES: The purpose of this study was to examine the performance of contemporary ICD pulse generators that failed or were replaced because of manufacturers recalls.
METHODS: ICD data were entered prospectively by nine participating centers. ICD pulse generator failure was defined as removal from service because the device was not functioning according to the manufacturer's specifications. A recalled ICD was a normally functioning pulse generator that was replaced as the result of a recall or advisory.
RESULTS: From 1998 to 2005, 1,220 ICDs failed and 135 were recalled and replaced. The average implant time of failed ICDs was 4.4 +/- 1.5 years and of recalled ICDs was 1.7 +/- 0.8 years. The average implant time of single- and dual-chamber ICDs with rate responsive or cardiac resynchronization (CRT-D) pacing capabilities was significantly shorter than the average implant time of single- or dual-chamber devices without these features (P <.001). ICDs that provided rate responsive or CRT-D pacing failed earlier because of battery depletion (P <.001) and were significantly more prone to unexpected electronic or housing failure (9% vs 5%, P = .008) and recalls (25% vs 1%, P <.0001). Major adverse events included death (n = 2), failure to convert ventricular tachyarrhythmias (n = 6), and inappropriate shocks (n = 11).
CONCLUSION: Based on our analysis of failed and recalled devices, the performance of contemporary ICDs has been adversely affected by premature battery depletion, electronic failure, and manufacturers' recalls. Additional studies are needed to precisely estimate ICD longevity and to determine the incidence of unexpected ICD failure.

Entities:  

Mesh:

Year:  2006        PMID: 16731462     DOI: 10.1016/j.hrthm.2006.02.011

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  12 in total

1.  ISHNE/EHRA expert consensus on remote monitoring of cardiovascular implantable electronic devices (CIEDs).

Authors:  Sergio Dubner; Angelo Auricchio; Jonathan S Steinberg; Panos Vardas; Peter Stone; Josep Brugada; Ryszard Piotrowicz; David L Hayes; Paulus Kirchhof; Günter Breithardt; Wojciech Zareba; Claudio Schuger; Mehmet K Aktas; Michal Chudzik; Suneet Mittal; Niraj Varma
Journal:  Ann Noninvasive Electrocardiol       Date:  2012-01       Impact factor: 1.468

2.  Implantable cardioverter-defibrillator FDA safety advisories: Impact on patient mortality and morbidity.

Authors:  Jay Sengupta; Arthur C Kendig; Marlene Goormastic; Eui-Seock Hwang; Elizabeth A Ching; Roy Chung; Bruce D Lindsay; Patrick J Tchou; Bruce L Wilkoff; Mark J Niebauer; David O Martin; Niraj Varma; Oussama Wazni; Walid Saliba; Mohamed Kanj; Mandeep Bhargava; Thomas Dresing; Tyler Taigen; Christopher Ingelmo; Mohamed Bassiouny; Edmond M Cronin; Bradley Wilsmore; John Rickard; Mina K Chung
Journal:  Heart Rhythm       Date:  2012-07-03       Impact factor: 6.343

3.  Remote monitoring of patients with cardiac implantable electronic devices: a Southeast Asian, single-centre pilot study.

Authors:  Paul Chun Yih Lim; Audry Shan Yin Lee; Kelvin Chi Ming Chua; Eric Tien Siang Lim; Daniel Thuan Tee Chong; Boon Yew Tan; Kah Leng Ho; Wee Siong Teo; Chi Keong Ching
Journal:  Singapore Med J       Date:  2016-07       Impact factor: 1.858

Review 4.  [ICD lead defects: diagnosis and therapeutical options].

Authors:  Christian G Wollmann; Dirk Böcker; Andreas Löher; Hans H Scheld; Günter Breithardt; Rainer Gradaus
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2009-02-11

5.  Formation of a national network for rapid response to device and lead advisories: The Canadian Heart Rhythm Society Device Advisory Committee.

Authors:  Andrew D Krahn; Christopher S Simpson; Ratika Parkash; Raymond Yee; Jean Champagne; Jeffrey S Healey; Doug Cameron; Bernard Thibault; Iqwal Mangat; Stanley Tung; Laurence Sterns; David H Birnie; Derek V Exner; Soori Sivakumaran; Ted Davies; Benoit Coutu; Eugene Crystal; Kevin Wolfe; Atul Verma; Elizabeth A Stephenson; Shubhayan Sanatani; Robert Gow; Sean Connors; Felix Ayala Paredes; Mike Turabian; Teresa Kus; Vidal Essebag; Martin Gardner
Journal:  Can J Cardiol       Date:  2009-07       Impact factor: 5.223

Review 6.  Complications from prophylactic replacement of cardiac implantable electronic device generators in response to United States Food and Drug Administration recall: A systematic review and meta-analysis.

Authors:  Emily P Zeitler; Divyang Patel; Vic Hasselblad; Gillian D Sanders; Sana M Al-Khatib
Journal:  Heart Rhythm       Date:  2015-04-03       Impact factor: 6.343

7.  Significant differences in the expected versus observed longevity of implantable cardioverter defibrillators (ICDs).

Authors:  Tali Shafat; Yael Baumfeld; Victor Novack; Yuval Konstantino; Guy Amit
Journal:  Clin Res Cardiol       Date:  2012-07-14       Impact factor: 5.460

8.  "Real life" longevity of implantable cardioverter-defibrillator devices.

Authors:  Antonis S Manolis; Themistoklis Maounis; Spyridon Koulouris; Vassilios Vassilikos
Journal:  Clin Cardiol       Date:  2017-05-22       Impact factor: 2.882

9.  Contributions of remote monitoring to the follow-up of implantable cardioverter-defibrillator leads under advisory.

Authors:  Laurence Guédon-Moreau; Philippe Chevalier; Christelle Marquié; Claude Kouakam; Didier Klug; Dominique Lacroix; Francois Brigadeau; Salem Kacet
Journal:  Eur Heart J       Date:  2010-06-30       Impact factor: 29.983

10.  Management of radiation oncology patients with a pacemaker or ICD: a new comprehensive practical guideline in The Netherlands. Dutch Society of Radiotherapy and Oncology (NVRO).

Authors:  Coen W Hurkmans; Joost L Knegjens; Bing S Oei; Ad J J Maas; G J Uiterwaal; Arnoud J van der Borden; Marleen M J Ploegmakers; Lieselot van Erven
Journal:  Radiat Oncol       Date:  2012-11-24       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.